Supraventricular Tachycardia by Concealed Bypass Tract.
10.18501/arrhythmia.2017.005
- Author:
Ki Hong LEE
1
Author Information
1. Cardiovascular Medicine, The Heart Center of Chonnam National University Hospital, Republic of Korea. drgood2@naver.com
- Publication Type:Review
- Keywords:
Supraventricular Tachycardia;
AVNRT
- MeSH:
Adenosine;
Amiodarone;
Atrioventricular Node;
Catheter Ablation;
Diltiazem;
Electrocardiography;
Flecainide;
Humans;
Incidence;
Propafenone;
Tachycardia;
Tachycardia, Supraventricular*;
Verapamil
- From:International Journal of Arrhythmia
2017;18(1):38-42
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Concealed bypass tract (CBT) results from incomplete development of the atrioventricular (AV) annulus. CBT conducts only in a retrograde direction, and therefore does not cause pre-excitation on standard electrocardiograms. The most common tachycardia associated with CBT is an orthodromic atrioventricular reentrant tachycardia (AVRT): a pathway involving anterograde circuitry through the AV node and His Purkinje system and retrograde conduction over the accessory pathway. Orthodromic AVRT accounts for approximately 90%-95% cases of AVRT. Most incidences of CBT occur at the left free wall. Vagal maneuvers and/or intravenous (IV) adenosine are recommended for first line acute management of AVRT. However, pharmacological therapy with IV diltiazem, verapamil, or beta blockers can also be effective for acute treatment for orthodromic AVRT in patients who do not show pre-excitation on their resting ECG during sinus rhythm. The first-line ongoing therapy for AVRT is catheter ablation of CBT; when catheter ablation is not indicated or preferred, oral beta blockers, diltiazem, verapamil, flecainide, propafenone, or amiodarone are recommended.
